DCP Logo
  • Home
  • About
    • DCP program
    • DCP program history
    • Structural Genomic Consortium
    • Probe contributions
  • Show Probes
    • All
    • Kinase
    • GPCR
    • Ion channel
    • Epigenetics
    • Other enzymes
    • Other targets
  • Order set
  • Download
  • Information
    • FAQ
    • Probe resources
    • Donate probes
    • Contact
    • Funding
    • Update history
All probes Probe criteria Further information Usage Order Properties Structure Compound analysis Potency Selectivity Data download
  • Probe criteria
  • Further information
  • Usage
  • Order
  • Properties
  • Structure
  • Compound analysis
  • Potency
  • Selectivity
  • Data download

Usage recommendations for probe BAY-1797 and control BAY-207


In cells

Use at concentration from 0.1 to 1 µM

Use the recommended concentration to avoid off-target toxicity and/or off-target activity. Using concentrations that are higher than recommended could lead to false positive or confounding results.

In vivo

Efficacy in mechanistic mouse model in vivo (CFA Model): 0, 12.5, 25, 50 mg/kg, p.o.; 1 single dose at 1h before PGE2 sampling
Efficacy in PD pain mouse model in vivo: 50 mg/kg, p.o.; 1 single dose each day at 1h before DWB; DWB testing at 24 and 48 h after CFA (Vehicle : EtOH/Solutol/NaCl 1:5:94)